Latest Share Chat

REMOVE ADS

Astrazeneca Share News (AZN)

Astrazeneca Information

Share Price Information for Astrazeneca (AZN)

Share Price is delayed by 15 minutes

Get Live Data

14,280.00 -38.00 (-0.27%)

Bid:

14,280.00

Ask:

14,282.00

Spread: 2.00 (0.014%)

Market Cap: £221.46b

Last checked at -

Intraday Astrazeneca Share Chart

REMOVE ADS

Astrazeneca News

AstraZeneca gets FDA approval for FluMist self-administration

(Alliance News) - AstraZeneca PLC on Friday announced that its influenza vaccine FluMist has been approved for self-administration in the US.

LONDON MARKET MIDDAY: Glum trade for FTSE 100 before Fed decides

(Alliance News) - Stock prices in London went into Wednesday's afternoon on weaker footing, with trade tepid ahead of the evening's Federal Reserve de...

AstraZeneca Fasenra treatment for EGPA approved in the US

(Alliance News) - AstraZeneca PLC on Wednesday announced Fasenra has been approved in the US to treat adult patients with eosinophilic granulomatosis ...

LONDON BRIEFING: Legal & General sells CALA arm for GBP1.35 billion

(Alliance News) - The FTSE 100 is called to open lower on Wednesday, as investors digest a UK inflation reading, and look ahead to a US interest rate ...

AstraZeneca's inflammatory disease drug Fasenra approved in the US

(Sharecast News) - AstraZeneca has received the green light for its Fasenra drug in the US, used to treat patients with a rare inflammatory disease.

TOP NEWS: AstraZeneca celebrates survival rate of Imfinzi-Imjudo mix

(Alliance News) - AstraZeneca PLC on Monday said that Imfinzi plus Imjudo showed a clinically meaningful overall survival benefit for patients with a ...

European stocks wrap up week on a high note; focus shifts to Fed

France's inflation at 0.2% in Aug. *

Daiichi, Astra's Enhertu shows clinical activity in brain metastases

(Alliance News) - Daiichi Sankyo Co Ltd and AstraZeneca PLC on Friday reported "substantial clinical activity" for Enhertu in a recent clinical trial.